Non-Current Assets
Other Non-Current Assets
Gilead Sciences Other Non-Current Assets decreased by 6.0% to $4.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $3.87B to $4.55B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows a downward trend with a -3.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
Significant changes may indicate shifts in long-term operational strategy or changes in accounting for specific non-core assets.
Detailed definition
This captures miscellaneous long-term assets that do not fit into specific categories like property, plant, equipment, o...
Peer comparison
Varies widely by company; usually represents a small percentage of total assets.
Metric ID:
non_current_assets_other_assets_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.55B | $4.74B | $4.96B | $5.13B | $4.86B | $4.62B | $4.80B | $4.95B | $5.11B | $4.20B | $4.79B | $5.19B | $4.77B | $5.49B | $3.77B | $3.87B | $4.03B | $4.87B | $4.85B | $4.55B |
| QoQ Change | — | -14.6% | +4.7% | +3.3% | -5.2% | -5.0% | +3.9% | +3.2% | +3.3% | -17.9% | +14.1% | +8.3% | -8.1% | +15.2% | -31.4% | +2.7% | +4.1% | +20.9% | -0.6% | -6.0% |
| YoY Change | — | — | — | — | -12.5% | -2.6% | -3.3% | -3.4% | +5.2% | -9.1% | -0.2% | +4.8% | -6.7% | +30.8% | -21.3% | -25.4% | -15.5% | -11.3% | +28.5% | +17.6% |
Range$3.77B – $5.55B
CAGR-4.1%
Avg YoY Growth-1.5%
Median YoY Growth-3.3%
Current Streak2 quarters decline
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other non-current assets?
- Gilead Sciences (GILD) reported other non-current assets of $4.55B in Q1 2026.
- How has Gilead Sciences's other non-current assets changed year-over-year?
- Gilead Sciences's other non-current assets increased by 17.6% year-over-year, from $3.87B to $4.55B.
- What is the long-term trend for Gilead Sciences's other non-current assets?
- Over 5 years (2020 to 2025), Gilead Sciences's other non-current assets has grown at a -3.2% compound annual growth rate (CAGR), from $5.71B to $4.85B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into standard reporting categories.